This is also in light of our recent results, showing that the Adnp+/– mouse mimics the human autism-like ADNP syndrome patient, and suggesting NAP as a drug candidate for treating this pathology (Hacohen-Kleiman et al., 2018). This evidence concerns the gene ADNP and ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder.